WeVote
Log In

Bill

Bill

HF 5119

Commissioner of health directed to conduct a feasibility study of establishing a mobile lung cancer screening program in greater Minnesota, and money appropriated.

2025-2026 Regular Session Introduced by Dan Wolgamott

A plan to study and report on a mobile lung cancer screening program for greater Minnesota, including costs, staffing, services, and access barriers.

Introduction and first reading, referred to Health Finance and Policy
#appropriations #healthandhealthdepartment
0
WeVote Research Nonpartisan
Bill Summary · HF 5119

Summary of HF 5119 (2025-2026) – Minnesota

Purpose and intent

  • Directs the Minnesota Commissioner of Health to conduct a feasibility study on establishing a mobile lung cancer screening program serving residents of greater Minnesota.
  • The bill contemplates a mobile unit equipped with a computed tomography (CT) scanner and staffed by appropriate health professionals to travel to various locations in greater Minnesota to screen residents for lung cancer.
  • It includes a one-time General Fund appropriation to fund the feasibility study and requires a report to the Legislature.

Key provisions and changes

  • Feasibility study scope (Section 1)
    • The Commissioner of Health must study the feasibility of a mobile lung cancer screening program for greater Minnesota, including: 1) Cost estimates for equipment, supplies, and mobile unit acquisition or rental, as well as other necessary equipment and supplies. 2) Staffing needs, including the types and numbers of health professionals and other personnel required to operate each mobile unit and associated staffing costs. 3) Services to be provided by each mobile unit, specifically screening for lung cancer and providing referrals when appropriate. 4) Identification of regions within greater Minnesota that face barriers to lung cancer screening, assessment of how a mobile program could improve access, and an estimate of the annual screening capacity (number of residents that could be screened by a mobile unit). 5) Identification and examination of other elements of the program as determined by the commissioner.

  • Reporting deadline (Section 1, subsection (b))

    • The commissioner must submit a formal report detailing the study’s findings to the chairs, ranking minority members, and cochairs of the legislative committees with jurisdiction over health policy and finance by February 1, 2027.

  • appropriation (Section 2)

    • Establishes a one-time appropriation of an unspecified amount from the General Fund to the Commissioner of Health in fiscal year 2027 to conduct the feasibility study.
    • Explicitly notes the appropriation is a one-time funding allocation.

Affected entities and beneficiaries

  • Primary: Minnesota Department of Health (Commissioner of Health) as the lead agency conducting the feasibility study.
  • Legislative stakeholders: Health policy and finance committees (chairs and ranking minority members, cochairs) who will receive the study report.
  • Greater Minnesota residents: Potential beneficiaries if the program advances to implementation, particularly those with limited access to lung cancer screening services due to geography, transportation, or healthcare access barriers.
  • Health system providers and local communities: May be affected by planning, staffing, and resource needs associated with a mobile screening program.

Procedural and timeline aspects

  • Introduction and referral: HF 5119 introduced and referred to Health Finance and Policy on May 6, 2026.
  • Study timeline: Commissioner is required to complete the feasibility study and deliver a final report by February 1, 2027.
  • Funding timeline: One-time General Fund appropriation authorized for fiscal year 2027 to support the feasibility study.

Notes and context

  • The bill focuses on feasibility rather than immediate implementation, meaning no program operations or funding for ongoing operations are authorized at this stage.
  • Details such as the number of mobile units, exact staffing models, cost projections, and region-by-region screening capacity would be addressed in the commissioner’s study.
  • The use of a mobile CT scanner implies considerations around safety, radiation exposure, equipment maintenance, data management, and patient follow-up that the study would need to evaluate.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.